Literature DB >> 25575726

Anti-GAD Antibody, Seizures, Cerebellar Ataxias and Vitiligo: A Diagnostic Challenge.

Hazael Flores-Cantu1, Carlos R Camara-Lemarroy, Hector J Calderon-Hernandez, Maria A Zapata-Rivera, Jesus Z Villareal-Perez, Hector J Villareal-Velazquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25575726     DOI： 10.1007/s12311-014-0625-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN： 1473-4222            Impact factor:   3.847


× No keyword cloud information.
  16 in total

1.  Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

Authors:  S Vulliemoz; G Vanini; A Truffert; C Chizzolini; M Seeck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

Review 2.  Hashimoto's encephalopathy and rare cases of hyperthyroidism (review and case report).

Authors:  J Payer; T Petrovic; L Baqi; L Lisy; P Langer
Journal:  Endocr Regul       Date:  2009-10

3.  Serum antibodies in epilepsy and seizure-associated disorders.

Authors:  K McKnight; Y Jiang; Y Hart; A Cavey; S Wroe; M Blank; Y Shoenfeld; A Vincent; J Palace; B Lang
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

4.  Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies.

Authors:  B Giometto; P Nicolao; M Macucci; B Tavolato; R Foxon; G F Bottazzo
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

5.  Cerebellar ataxia, peripheral neuropathy, "gluten sensitivity" and anti-neuronal autoantibodies.

Authors:  Robert J Lock; Dsna Pengiran Tengah; Alistair Jk Williams; John J Ward; Polly J Bingley; Adrian J Wills; David J Unsworth
Journal:  Clin Lab       Date:  2006       Impact factor: 1.138

6.  The aetiology of sporadic adult-onset ataxia.

Authors:  M Abele; K Bürk; L Schöls; S Schwartz; I Besenthal; J Dichgans; C Zühlke; O Riess; T Klockgether
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

7.  Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.

Authors:  Kazunori Nanri; Mitsunori Okita; Masafumi Takeguchi; Takeshi Taguchi; Tomoko Ishiko; Hirohiko Saito; Takao Otsuka; Hiroshi Mitoma; Kiyoshi Koizumi
Journal:  Intern Med       Date:  2009-05-15       Impact factor: 1.271

8.  Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.

Authors:  H Bárová; J Perusicová; M Hill; I Sterzl; K Vondra; Z Masek
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

9.  Low-titer anti-GAD-antibody-positive cerebellar ataxia.

Authors:  Kazunori Nanri; Hisayoshi Niwa; Hiroshi Mitoma; Asako Takei; Junko Ikeda; Toshihide Harada; Mitsunori Okita; Masafumi Takeguchi; Takeshi Taguchi; Hidehiro Mizusawa
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

10.  Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.

Authors:  R K Marwaha; M K Garg; N Tandon; Ratnesh Kanwar; A Narang; A Sastry; A Saberwal; Kuntal Bhadra
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375
View more
  1 in total

Review 1.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.